Literature DB >> 11953349

Management of uninvestigated dyspepsia: review and commentary.

Anthony Axon1.   

Abstract

Up to 40% of individuals complain of dyspepsia but only 25% of these present to their general practitioner. If symptoms have been present for a relatively short period the majority can be managed by reassurance and symptomatic treatment. Those with a longer history require empirical treatment with more powerful medication, endoscopy, testing for Helicobacter pylori, or a combination of these approaches. There is some debate about whether the treatment of Helicobacter pylori infection is an appropriate strategy for patients with dyspepsia. It is the general practitioner who determines how the uninvestigated patient with dyspepsia will be managed because those referred to hospital usually undergo endoscopy at an early stage.

Entities:  

Mesh:

Year:  2002        PMID: 11953349      PMCID: PMC1867705          DOI: 10.1136/gut.50.suppl_4.iv51

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis.

Authors:  J Labenz; A L Blum; E Bayerdörffer; A Meining; M Stolte; G Börsch
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

2.  Opposing time trends of peptic ulcer and reflux disease.

Authors:  H B el-Serag; A Sonnenberg
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

3.  Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

Authors:  A L Blum; N J Talley; C O'Moráin; S V van Zanten; J Labenz; M Stolte; J A Louw; A Stubberöd; A Theodórs; M Sundin; E Bolling-Sternevald; O Junghard
Journal:  N Engl J Med       Date:  1998-12-24       Impact factor: 91.245

Review 4.  AGA technical review: evaluation of dyspepsia. American Gastroenterological Association.

Authors:  N J Talley; M D Silverstein; L Agréus; O Nyrén; A Sonnenberg; G Holtmann
Journal:  Gastroenterology       Date:  1998-03       Impact factor: 22.682

Review 5.  Early gastric cancer in Europe.

Authors:  S M Everett; A T Axon
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

6.  Heartburn treatment in primary care: randomised, double blind study for 8 weeks.

Authors:  J G Hatlebakk; A Hyggen; P H Madsen; P O Walle; T Schulz; P Mowinckel; T Bernklev; A Berstad
Journal:  BMJ       Date:  1999-08-28

7.  Serology for Helicobacter pylori compared with symptom questionnaires in screening before direct access endoscopy.

Authors:  M A Mendall; R P Jazrawi; J M Marrero; N Molineaux; J Levi; J D Maxwell; T C Northfield
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

8.  Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).

Authors:  N J Talley; V Meineche-Schmidt; P Paré; M Duckworth; P Räisänen; A Pap; H Kordecki; V Schmid
Journal:  Aliment Pharmacol Ther       Date:  1998-11       Impact factor: 8.171

9.  Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy? The Italian Helicobacter pylori Study Group.

Authors:  D Vaira; V Stanghellini; M Menegatti; D Palli; R Corinaldesi; M Miglioli
Journal:  Endoscopy       Date:  1997-09       Impact factor: 10.093

10.  Diagnostic tests for Helicobacter pylori--can they help select patients for endoscopy?

Authors:  A G Fraser; M R Ali; S McCullough; N J Yeates; A Haystead
Journal:  N Z Med J       Date:  1996-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.